EUVIMEDEUVIMED entdecken
Crossref

Axillary Node Metastases of Medullary Thyroid Cancer: A Hallmark of Terminal Disease

Andreas Machens iD, Kerstin Lorenz iD, Frank Weber, Henning Dralle

Hormone and Metabolic Research · 01.06.2024 · 56 (06) · 429-434

DOI: 10.1055/a-2172-9263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.06.2024. Verfasst von Andreas Machens und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University of Halle-Wittenberg Faculty of Medicine, Halle, Germany. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Lymphatic Metastasis, Carcinoma, Neuroendocrine, Axilla. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Little is known about axillary node metastasis of medullary thyroid cancer (MTC). To address this, a comparative study of patients with and without axillary node metastases of MTC was conducted. Among 1215 consecutive patients with MTC, 482 patients had node-negative MTC and 733 patients node-positive MTC. Among the 733 patients with node-positive MTC, 4 patients (0.5%) had axillary node metastases, all of which were ipsilateral. Patients with axillary node metastases had 5.7–6.9-fold more node metastases removed, both at the authors’ institution (medians of 34.5 vs. 5 metastases; p=0.011) and in total (medians of 57 vs. 10 metastases; p=0.013), developed more frequently distant metastases (3 of 4 vs. 178 of 729 patients, or 75 vs. 24%; p=0.049), specifically to bone (2 of 4 vs. 67 of 729 patients, or 50 vs. 9%; p=0.046) and brain (1 of 4 vs. 4 of 729 patients, or 25 vs. 0.5%; p=0.027), and more often succumbed to cancer-specific death (3 of 4 vs. 52 of 729 patients, or 75 vs. 14%; p=0.005). Altogether, patients with axillary node metastases revealed 4–8-fold more node metastases in the ipsilateral lateral neck (medians of 11 vs. 3 metastases; p=0.021) and in the ipsilateral central neck (medians of 8 vs. 1 metastases; p=0.079) patients without axillary node metastases. Cancer-specific survival of patients with vs. patients without axillary node metastases of MTC was significantly shorter (means of 41 vs. 224 months; plog-rank

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsLymphatic MetastasisCarcinoma, NeuroendocrineAxillaHumansMaleFemaleMiddle AgedAdultAgedLymph NodesAged, 80 and overYoung AdultAdolescent

Autor:innen und Institutionen

  • Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University of Halle-Wittenberg Faculty of Medicine, Halle, Germany.
  • Department of General, Visceral and Transplantation Surgery, Division of Endocrine Surgery, University of Duisburg-Essen, Faculty of Medicine, Essen, Germany.

ORCID-Profile: Andreas Machens, Kerstin Lorenz

Zitieren

APA

Machens, A., Lorenz, K., Weber, F., & Dralle, H. (2024). Axillary Node Metastases of Medullary Thyroid Cancer: A Hallmark of Terminal Disease. Hormone and Metabolic Research, 56(06), 429-434. https://doi.org/10.1055/a-2172-9263

Vancouver

Machens A, Lorenz K, Weber F, Dralle H. Axillary Node Metastases of Medullary Thyroid Cancer: A Hallmark of Terminal Disease. Hormone and Metabolic Research. 2024;56(06):429-434. doi:10.1055/a-2172-9263

BibTeX
@article{Machens2024,
  author = {Machens, Andreas and Lorenz, Kerstin and Weber, Frank and Dralle, Henning},
  title = {Axillary Node Metastases of Medullary Thyroid Cancer: A Hallmark of Terminal Disease},
  journal = {Hormone and Metabolic Research},
  year = {2024},
  volume = {56},
  number = {06},
  pages = {429--434},
  doi = {10.1055/a-2172-9263}
}
Kostenlos starten →